Genscript Biotech Dividend
Dividend of Genscript Biotech (1548.HK) as of Oct 8, 2026.
Get this data via API
Financial Data API
Dividend
0.00USD
Dividend yield
0.03 %
Last updated:
How much dividend does Genscript Biotech 2026 pay?
According to the latest status from October 2026, Genscript Biotech paid a total of 0.00 USD per share in dividends within the last 12 months. With the current Genscript Biotech price of 40.70 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.
Genscript Biotech currently offers a dividend yield of about 0.03%. The payout ratio is around 10% of earnings.
Historical Genscript Biotech Dividends
| Paydate | Dividend |
|---|---|
| 0.01USD |
The Genscript Biotech Dividend history
3 Years
10 Years
25 Years
Max
| YEAR | Dividend | YoY |
|---|---|---|
| est | 0.01USD | 0.00% |
| est | 0.01USD | 0.00% |
| est | 0.01USD | 0.00% |
| est | 0.01USD | 0.00% |
| est | 0.01USD | 0.00% |
| est | 0.01USD | — |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | -100.00% | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — | |
| 0.00USD | — |
Is the Genscript Biotech Dividend Safe?
Genscript Biotech has been increasing the dividend for 0 years.
Analysts expect a Dividend Cut of -100.00% for the current fiscal year.
Genscript Biotech dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Dividend Details
Understanding Genscript Biotech's Dividend Distributions
Genscript Biotech’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Genscript Biotech's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Genscript Biotech's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Genscript Biotech’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Genscript Biotech Stock analysis
Frequently Asked Questions about Genscript Biotech stock
Over the past 12 months, Genscript Biotech paid a dividend of 0.01 USD . This corresponds to a dividend yield of about 0.03 %. For the coming 12 months, Genscript Biotech is expected to pay a dividend of 0.01 USD.
The current dividend yield of Genscript Biotech is 0.03 %.
Genscript Biotech paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0.01 USD are expected. This corresponds to a dividend yield of 0.22 %.
Genscript Biotech is assigned to the 'Health' sector.
To receive the latest dividend of Genscript Biotech from 6/21/2017 amounting to 0.01 USD, you needed to have the stock in your portfolio before the ex-date on 6/5/2017.
The last dividend was paid out on 6/21/2017.
In the year 2017, Genscript Biotech distributed 0.01 USD as dividends.
The dividends of Genscript Biotech are distributed in USD.
All Key Metrics — Genscript Biotech
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth